Cited by CrossRef (7)
- Hossein Abbaszadeh, Farzaneh Ghorbani, Sanaz Abbaspour-Aghdam, Amin Kamrani, Hamed Valizadeh, Mehdi Nadiri, Armin Sadeghi, Karim Shamsasenjan, Farhad Jadidi-Niaragh, Leila Roshangar, Majid Ahmadi. Chronic obstructive pulmonary disease and asthma: mesenchymal stem cells and their extracellular vesicles as potential therapeutic tools. Stem Cell Res Ther 2022;13
- Yosep Mo, Sung-Yoon Kang, Ji-Young Bang, Yujin Kim, Jiung Jeong, Eui-Man Jeong, Hye Young Kim, Sang-Heon Cho, Hye-Ryun Kang. Intravenous Mesenchymal Stem Cell Administration Modulates Monocytes/Macrophages and Ameliorates Asthmatic Airway Inflammation in a Murine Asthma Model. Mol.Cells 2022;45:833
- Sun Mi Choi, Yosep Mo, Ji-Young Bang, Young Gyun Ko, Yoon Hae Ahn, Hye Young Kim, Jaemoon Koh, Jae-Joon Yim, Hye-Ryun Kang. Classical monocyte-derived macrophages as therapeutic targets of umbilical cord mesenchymal stem cells: comparison of intratracheal and intravenous administration in a mouse model of pulmonary fibrosis. Respir Res 2023;24
- Lan-lan Mi, Wei-wei Guo, Zhipeng Xu. Crosstalk between ILC2s and Th2 CD4+ T Cells in Lung Disease. Journal of Immunology Research 2022;2022:1
- Yosep Mo, Hanbit Kang, Ji-Young Bang, Jae Woo Shin, Hye Young Kim, Sang-Heon Cho, Hye-Ryun Kang. Intratracheal administration of mesenchymal stem cells modulates lung macrophage polarization and exerts anti-asthmatic effects. Sci Rep 2022;12
- Narayan Bashyal, Tae-Young Lee, Da-Young Chang, Jin-Hwa Jung, Min Gyeong Kim, Rakshya Acharya, Sung-Soo Kim, Il-Hoan Oh, Haeyoung Suh-Kim. Improving the Safety of Mesenchymal Stem Cell-Based Ex Vivo Therapy Using Herpes Simplex Virus Thymidine Kinase. Mol.Cells 2022;45:479
- Yosep Mo, Yujin Kim, Ji-Young Bang, Jiung Jung, Chun-Geun Lee, Jack A. Elias, Hye-Ryun Kang. Mesenchymal Stem Cells Attenuate Asthmatic Inflammation and Airway Remodeling by Modulating Macrophages/Monocytes in the IL-13-Overexpressing Mouse Model. Immune Netw 2022;22
